metformin has been researched along with Chorea Disorders in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyer, T | 1 |
| Dafotakis, M | 1 |
| Piccolo, I | 1 |
| Sterzi, R | 1 |
| Thiella, G | 1 |
2 other studies available for metformin and Chorea Disorders
| Article | Year |
|---|---|
[Hemiballism-Hemichorea Induced by Non-Ketotic Hyperglycemia].
Topics: Aged; Chorea; Dyskinesias; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Metformin | 2019 |
Chorea in hyperglycemia.
Topics: Aged; Aged, 80 and over; Brain; Chorea; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gl | 1998 |